These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38824957)

  • 1. The role of dementia in the association between APOE4 and all-cause mortality: pooled analyses of two population-based cohort studies.
    Régy M; Dugravot A; Sabia S; Helmer C; Tzourio C; Hanseeuw B; Singh-Manoux A; Dumurgier J
    Lancet Healthy Longev; 2024 Jun; 5(6):e422-e430. PubMed ID: 38824957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leading determinants of incident dementia among individuals with and without the apolipoprotein E ε4 genotype: a retrospective cohort study.
    Ye S; Roccati E; Wang W; Zhu Z; Kiburg K; Huang Y; Zhang X; Zhang X; Liu J; Tang S; Hu Y; Ge Z; Yu H; He M; Shang X
    BMC Neurol; 2024 Feb; 24(1):71. PubMed ID: 38378514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.
    Corrada MM; Paganini-Hill A; Berlau DJ; Kawas CH
    Alzheimers Dement; 2013 Jan; 9(1):12-8. PubMed ID: 23123227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
    Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
    J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic Propensity for Longevity, APOE-ε4 Status, Dementia Diagnosis, and Risk for Cause-Specific Mortality: A Large Population-Based Longitudinal Study of Older Adults.
    Ajnakina O; Shamsutdinova D; Stahl D; Steptoe A
    J Gerontol A Biol Sci Med Sci; 2023 Oct; 78(11):1973-1982. PubMed ID: 37434484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.
    Beydoun MA; Boueiz A; Abougergi MS; Kitner-Triolo MH; Beydoun HA; Resnick SM; O'Brien R; Zonderman AB
    Neurobiol Aging; 2012 Apr; 33(4):720-731.e4. PubMed ID: 20619505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a wide range of chronic diseases and apolipoprotein E4 genotype with subsequent risk of dementia in community-dwelling adults: A retrospective cohort study.
    Shang X; Zhu Z; Zhang X; Huang Y; Zhang X; Liu J; Wang W; Tang S; Yu H; Ge Z; Yang X; He M
    EClinicalMedicine; 2022 Mar; 45():101335. PubMed ID: 35299656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years.
    Stocker H; Trares K; Beyer L; Perna L; Rujescu D; Holleczek B; Beyreuther K; Gerwert K; Schöttker B; Brenner H
    Alzheimers Res Ther; 2023 Jul; 15(1):129. PubMed ID: 37516890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
    Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM;
    Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Education and Cardiovascular Health as Effect Modifiers of APOE ε4 on Dementia: The Atherosclerosis Risk in Communities Study.
    Lee M; Hughes TM; George KM; Griswold ME; Sedaghat S; Simino J; Lutsey PL
    J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1199-1207. PubMed ID: 34614170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of Dementia-Related Mortality: The Cohort of Norway (CONOR).
    Strand BH; Rosness TA; Engedal K; Magnus P; Bergem AL; Schirmer H; Bjertness E; Knudsen GP
    Dement Geriatr Cogn Disord; 2015; 40(3-4):137-47. PubMed ID: 26088392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.
    Tao Q; Ang TFA; DeCarli C; Auerbach SH; Devine S; Stein TD; Zhang X; Massaro J; Au R; Qiu WQ
    JAMA Netw Open; 2018 Oct; 1(6):e183597. PubMed ID: 30646251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of moderate and vigorous physical activity with incidence of type 2 diabetes and subsequent mortality: 27 year follow-up of the Whitehall II study.
    Yerramalla MS; Fayosse A; Dugravot A; Tabak AG; Kivimäki M; Singh-Manoux A; Sabia S
    Diabetologia; 2020 Mar; 63(3):537-548. PubMed ID: 31792574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
    Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
    Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
    Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
    Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: results from The 90+ Study.
    Kravitz BA; Corrada MM; Kawas CH
    J Am Geriatr Soc; 2009 Apr; 57(4):641-6. PubMed ID: 19245412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.